m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT00563
|
[1], [2], [3] | |||
: m6A sites
Indirect
Enhancement
RNA modification
SOX2
SOX2
METTL1
Methylation
: modification sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) | READER | |||
| m6A Target | Differentiation antagonizing non-protein coding RNA (DANCR) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | RNA modification (RNAMod) >> N7-methylguanosine (m7G) | ||||
| Epigenetic Regulator | Methyltransferase-like protein 1 (METTL1) | WRITER | View Details | ||
| Regulated Target | Transcription factor SOX-2 (SOX2) | View Details | |||
| Crosstalk Relationship | m6A → m7G | Enhancement | |||
| Crosstalk Mechanism | m6A modification indirectly impacts RNA modification through downstream signaling pathways | ||||
| Crosstalk Summary | IGF2BP2 interacts with Differentiation antagonizing non-protein coding RNA (DANCR), increasing its m6A level and promoting its physical interaction with Transcription factor SOX-2 (SOX2), which was regulated by METTL1-mediated m7G modification. | ||||
In-vitro Model |
iPSC (Mouse induced pluripotent stem cells (iPSCs)) | ||||
| BxPC-3 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0186 | ||
| SW1990 | Pancreatic adenocarcinoma | Homo sapiens | CVCL_1723 | ||
References
: m6A sites
: modification sites